AwardedGermanyGoodsFramework agreement
Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V i. V. m § 130c Abs. 1 SGB V zum Wirkstoff Depemokimab
- Published
- Published 12 May 2026
Overview
AOK Baden-Württemberg has concluded a pharmaceutical rebate agreement with GlaxoSmithKline GmbH & Co. KG for the active ingredient Depemokimab (Exdensur®) under German social security law provisions § 130a Abs. 8 SGB V and § 130c Abs. 1 SGB V. The agreement was awarded on 28 April 2026, with the exact contract value dependent on unknown factors and reported as a notional amount based on current threshold values.
Key details
- Country
- Germany
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Contract type
- Framework agreement
- Published
- 12 May 2026
Pharmaceutical products
Award outcome
- Award date
- 28 April 2026
- Contract period
- 1 May 2026 → 30 April 2028
- GlaxoSmithKline GmbH & Co. KG
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
11 May 2026
Contracting authority
AOK Baden-Württemberg
Procuring entityStuttgart, Germany
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.